126 related articles for article (PubMed ID: 11501528)
1. Measurement of atherosclerosis progression.
Young JH
Lancet; 2001 Jul; 358(9278):328-9. PubMed ID: 11501528
[No Abstract] [Full Text] [Related]
2. Measurement of atherosclerosis progression.
Wierzbicki AS; Crook MA; Reynolds TM; Mikhalidis DP
Lancet; 2001 Jul; 358(9278):329-30. PubMed ID: 11501530
[No Abstract] [Full Text] [Related]
3. Atorvastatin versus simvastatin.
Calder RA
Am J Cardiol; 1997 Dec; 80(12):1646. PubMed ID: 9416964
[No Abstract] [Full Text] [Related]
4. Effectiveness of low doses of simvastatin versus atorvastatin: resolving conflicting evidence.
Chong C; Kelly S; Bradley M
Clin Ther; 2002 Feb; 24(2):325-8. PubMed ID: 11911562
[No Abstract] [Full Text] [Related]
5. Effects of simvastatin and atorvastatin in hypercholesterolemic patients.
Bolaman Z; Kadikoylu G
Clin Ther; 2003 Oct; 25(10):2631-3. PubMed ID: 14667963
[No Abstract] [Full Text] [Related]
6. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
Kastelein JJ; van Leuven SI; Burgess L; Evans GW; Kuivenhoven JA; Barter PJ; Revkin JH; Grobbee DE; Riley WA; Shear CL; Duggan WT; Bots ML;
N Engl J Med; 2007 Apr; 356(16):1620-30. PubMed ID: 17387131
[TBL] [Abstract][Full Text] [Related]
7. Lipid-lowering with atorvastatin improves tissue characteristics of carotid plaque.
Katakami N; Sakamoto K; Kaneto H; Matsuhisa M; Hori M; Yamasaki Y; Kosugi K; Waki H
Atherosclerosis; 2005 Dec; 183(2):369-71. PubMed ID: 16162349
[No Abstract] [Full Text] [Related]
8. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
[TBL] [Abstract][Full Text] [Related]
9. [Thoughts about the results of the "IDEAL" study].
Kalina A
Orv Hetil; 2006 May; 147(21):993-5. PubMed ID: 16812974
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemia.
Farnier M; Portal JJ; Maigret P
J Cardiovasc Pharmacol Ther; 2000 Jan; 5(1):27-32. PubMed ID: 10687671
[TBL] [Abstract][Full Text] [Related]
11. [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
Einecke D
MMW Fortschr Med; 2003 Dec; 145(51-52):38. PubMed ID: 14974329
[No Abstract] [Full Text] [Related]
12. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of vitamin E compared with either simvastatin or atorvastatin in preventing the progression of atherosclerosis in homozygous familial hypercholesterolemia.
Raal FJ; Pilcher GJ; Veller MG; Kotze MJ; Joffe BI
Am J Cardiol; 1999 Dec; 84(11):1344-6, A7. PubMed ID: 10614803
[TBL] [Abstract][Full Text] [Related]
14. Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia.
van Tits LJ; Smilde TJ; van Wissen S; de Graaf J; Kastelein JJ; Stalenhoef AF
J Investig Med; 2004 Apr; 52(3):177-84. PubMed ID: 15222407
[TBL] [Abstract][Full Text] [Related]
15. "Major surprise" in a new study means likely changes in treatment.
Heart Advis; 2004 May; 7(5):2. PubMed ID: 15195616
[No Abstract] [Full Text] [Related]
16. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
März W
MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971
[TBL] [Abstract][Full Text] [Related]
17. Statins for patients with type 2 diabetes.
Auer J; Berent R; Weber T; Eber B
Lancet; 2004 Nov 27-Dec 3; 364(9449):1933-4. PubMed ID: 15566997
[No Abstract] [Full Text] [Related]
18. Measurement of atherosclerosis progression.
Tang R; Bond MG; Schminke U
Lancet; 2001 Jul; 358(9278):328; author reply 329. PubMed ID: 11501529
[No Abstract] [Full Text] [Related]
19. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
Weizel A; Sawicki PT
MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Plans-Rubió P
Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
